Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea

Jun 21, 20231 min read

Unilateral transvenous PNS with Remedē System in patients with CSA is associated with a high response to therapy through 36 months follow-up as well as echocardiography parameters through 24 months. The benefits appear to be sustained with no safety concerns.

Recent Posts

See All

Diagnosis and management of sleep apnea by a clinical nurse: a non-inferiority randomized clinical trial

Association between risk of obstructive sleep apnea and cognitive performance,frailty, and quality of life among older adults with atrial fibrillation

Improving performance on night shift: a study of resident sleep strategies

Night shift work is an unavoidable aspect of an internal medicine residency. Given the gravity of responsibility an internal medicine...

Long-term efficacy and safety of phrenic nerve stimulation for the treatment of central sleep apnea

Recent Posts

Comments